Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Smiley
K Stuart

Showing results (441-450 of 476) with videos related to

Pageof 48
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 12, 2018
Pervasive iron limitation at subsurface chlorophyll maxima of the California CurrentShane L Hogle, Christopher L Dupont, Brian M Hopkinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
Leishmania major Friedlin chromosome 1 has an unusual distribution of protein-coding genesP J Myler, L Audleman, T deVos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 30, 2018
A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid LeukemiaTodd A Fehniger, Jeffrey S Miller, Robert K Stuart, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 10, 2021
Long-term serological follow-up after primary Coxiella burnetii infection in patients with vascular risk factors for chronic Q feverSheila B Buijs, Sanne K Stuart, Jan Jelrik Oosterheert, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2019
A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemiasTara L Lin, Laura F Newell, Robert K Stuart, et al.
Leukemia Research|September 22, 2019
Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemiaDaniel J DeAngelo, Alison R Walker, Richard F Schlenk, et al.
The ISME Journal|May 17, 2025
Spatially structured bacterial interactions alter algal carbon flow to bacteriaHyungseok Kim, Vanessa L Brisson, John R Casey, et al.
Leukemia & Lymphoma|November 26, 2019
Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemiaJonathan E Kolitz, Stephen A Strickland, Jorge E Cortes, et al.
Nature Communications|September 13, 2023
Single-cell isotope tracing reveals functional guilds of bacteria associated with the diatom Phaeodactylum tricornutumXavier Mayali, Ty J Samo, Jeff A Kimbrel, et al.
British Journal of Haematology|November 30, 2010
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemiaAnjali S Advani, Holly M Gundacker, Olga Sala-Torra, et al.
Pageof 48

Showing results (441-450 of 476) with videos related to

Sort By:
Pageof 48
Proceedings of the National Academy of Sciences of the United States of America|December 12, 2018
Pervasive iron limitation at subsurface chlorophyll maxima of the California CurrentShane L Hogle, Christopher L Dupont, Brian M Hopkinson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
Leishmania major Friedlin chromosome 1 has an unusual distribution of protein-coding genesP J Myler, L Audleman, T deVos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 30, 2018
A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid LeukemiaTodd A Fehniger, Jeffrey S Miller, Robert K Stuart, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 10, 2021
Long-term serological follow-up after primary Coxiella burnetii infection in patients with vascular risk factors for chronic Q feverSheila B Buijs, Sanne K Stuart, Jan Jelrik Oosterheert, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2019
A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemiasTara L Lin, Laura F Newell, Robert K Stuart, et al.
Leukemia Research|September 22, 2019
Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemiaDaniel J DeAngelo, Alison R Walker, Richard F Schlenk, et al.
The ISME Journal|May 17, 2025
Spatially structured bacterial interactions alter algal carbon flow to bacteriaHyungseok Kim, Vanessa L Brisson, John R Casey, et al.
Leukemia & Lymphoma|November 26, 2019
Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemiaJonathan E Kolitz, Stephen A Strickland, Jorge E Cortes, et al.
Nature Communications|September 13, 2023
Single-cell isotope tracing reveals functional guilds of bacteria associated with the diatom Phaeodactylum tricornutumXavier Mayali, Ty J Samo, Jeff A Kimbrel, et al.
British Journal of Haematology|November 30, 2010
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemiaAnjali S Advani, Holly M Gundacker, Olga Sala-Torra, et al.
Pageof 48